{
}
Bristol Myers Squibb has filed a lawsuit against the federal government over a rejected plan to implement a 340B rebate model for drug discounts to hospitals, claiming the decision by HHS was unlawful. The company argues that its model would enhance compliance and transparency while addressing issues of abuse within the program. BMS intends to start this model with its Eliquis product in spring 2025, despite HHS's disapproval citing statutory inconsistencies.
Biocon shares surged over 4% following the U.S. FDA's approval of Yesintek, a biosimilar to J&J's Stelara, for treating Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. The stock has risen 47% year-to-date, outperforming the Nifty 50's 11% increase. This marks the seventh consecutive day of gains for Biocon, which has a licensing agreement with Janssen to commercialize Yesintek in the U.S. by February 2025.
Amgen's MariTide obesity drug showed mid-stage trial results in line with competitors, while Stryker's Mako robotic product and outpatient focus position it as a strong investment. Pfizer's potential divestment of its hospital drugs business could enhance its core growth, and Boston Scientific's promising pipeline supports its long-term outlook. CFRA maintains "buy" ratings for these companies, with specific price targets reflecting their growth potential.
Venture capital is increasingly shaping innovation in Europe, with regions like 'Swiss Valley' and 'Silicon Canals' emerging as key hubs. In 2024, Europe holds USD 47.2 billion in 'dry powder' for VC investments, particularly in healthcare and technology, despite facing competition and economic uncertainties. The growth of start-ups in these sectors is supported by strong academic institutions and strategic acquisitions by major companies, highlighting a vibrant landscape for future investment.
Venture capital is increasingly shaping Europe's innovation landscape, with regions like 'Swiss Valley' and 'Silicon Canals' emerging as key hubs. Switzerland's healthcare sector attracts significant investments, while Amsterdam fosters a diverse start-up ecosystem. As sustainability becomes a priority, VC firms are integrating ESG criteria, driving innovation in climate tech and renewable energy.
JLABS Singapore, in collaboration with the Singapore Economic Development Board, is accelerating early-stage bioscience innovations, having onboarded 35 companies in its first year. The incubator focuses on precision medicine and has seen notable successes, including VerImmune's $4.5 million funding and Vivo Surgical's WIPO Global Award. With a robust ecosystem and strong investor relations, JLABS aims to transform healthcare solutions in Asia.
Johnson & Johnson (NYSE: JNJ) reported a quarterly EPS of $2.42, exceeding estimates, with revenue of $22.47 billion, up 5.2% year-over-year. The company announced a quarterly dividend of $1.24, yielding 3.19%, while analysts maintain a "Moderate Buy" rating with a target price of $175.94. Despite solid fundamentals, some analysts suggest exploring alternative investment options.
The healthcare consumables market is projected to grow from $281.63 billion in 2023 to $466.65 billion by 2028, driven by rising hospital admissions, chronic disease prevalence, and the adoption of biodegradable products. Major players are focusing on eco-friendly innovations to enhance sustainability and meet increasing healthcare demands.
AstraZeneca’s Enhertu, a leading breast cancer treatment, has been approved for reimbursement by China’s state-run medical insurance, enhancing the company’s sales prospects amid an ongoing investigation involving some senior executives. The drug is one of 91 added to the National Reimbursement Drug List, effective January 1, alongside treatments from Johnson & Johnson, Bristol Myers Squibb, Roche, Sanofi, and Merck for various conditions.
Europe is emerging as a vibrant hub for venture capital, driven by a surge in sustainability and climate technology investments. Regions like 'Swiss Valley' and the 'Silicon Canals' are fostering innovation, particularly in healthcare and biotech, as established companies acquire startups to enhance their portfolios. With a growing focus on ESG criteria, the landscape is ripe for transformative breakthroughs that promise both financial returns and societal impact.
Johnson & Johnson
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Bristol Myers Squibb Sues HHS Over Controversial 340B Rebate Model Changes
13:30 03.12.2024
Biocon shares surge after US FDA approves Yesintek biosimilar for treatment
08:00 02.12.2024
Top Health Care Stocks to Consider for Investment in 2025
Johnson & Johnson
Gilead Sciences Inc
Boston Scientific Corp
Amgen Inc.
Stryker Corp
Bristol-Myers Squibb Co
Merck & Co., Inc.
Eli Lilly & Co
Thermo Fisher Scientific Inc.
Pfizer Inc.
USA
Sel Hardy
Robert F. Kennedy Jr.
Paige Meyers
Show more
20:06 29.11.2024
emerging venture capital hubs in europe focus on sustainability and innovation
Swiss Franc
Euro
United States Dollar
Swedish Krona
Adyen N.V.
Elastic N.V.
Just Eat Takeaway.com N.V.
Mollie
Wetransfer B.V.
Spotify Technology S.A.
iZettle
PayPal Holdings, Inc.
Johnson & Johnson
Novo Nordisk A/S
Boehringer Ingelheim KG
Ironwood Pharmaceuticals, Inc.
NLD
SWE
GBR
CHE
USA
Show more
14:08 29.11.2024
emerging venture capital hubs in europe driving innovation and growth
Swiss Franc
Swedish Krona
Euro
United States Dollar
Novo Nordisk A/S
Johnson & Johnson
Adyen N.V.
Wetransfer B.V.
Boehringer Ingelheim KG
iZettle
Ironwood Pharmaceuticals, Inc.
Elastic N.V.
Mollie
Just Eat Takeaway.com N.V.
Spotify Technology S.A.
PayPal Holdings, Inc.
NLD
GBR
CHE
SWE
Show more
14:08 29.11.2024
jlabs singapore empowering early-stage biotech companies through collaboration and mentorship
09:00 29.11.2024
analysts raise concerns over johnson and johnson despite strong earnings report
14:13 28.11.2024
healthcare consumables market poised for rapid growth driven by sustainability trends
Nipro Corporation
Medi-Plast Ltd.
Fresenius Kabi AG
Smith & Nephew plc
Alcon Laboratories Inc.
B. Braun Melsungen AG
Zimmer Biomet Holdings, Inc.
Invacare Corporation
BioLife Solutions, Inc.
Boston Scientific Corporation
Johnson & Johnson
Siemens Healthineers AG
Abbott Laboratories
Cardinal Health, Inc.
GE HealthCare Technologies Inc.
Coloplast A/S
Philips Healthcare
DexCom, Inc.
Ortho-Clinical Diagnostics Inc.
Terumo Corporation
AngioDynamics, Inc.
Becton Dickinson and Company (BD)
Stryker Corporation
Hollister Incorporated
Hologic, Inc.
3M Company
Brian Johnson
Show more
11:38 28.11.2024
AstraZeneca's Enhertu approved for reimbursement in China amid ongoing probe
United States Dollar
Sanofi
Merck & Co., Inc.
Bristol-Myers Squibb Company
Roche Holding AG
AstraZeneca PLC
Johnson & Johnson
GBR
Brian Johnson
Show more
08:22 28.11.2024
europe's venture capital landscape drives innovation in sustainability and healthcare
Euro
Swiss Franc
United States Dollar
Novo Nordisk A/S
Boehringer Ingelheim KG
Novartis AG
Johnson & Johnson
Hoffmann-La Roche AG
Oatly Group AB
Ironwood Pharmaceuticals, Inc.
CHE
SWE
NLD
GBR
Michael Brunner
Erasmus Elsner
Show more
04:16 28.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
Stock Market Updates
Government Economic Policies
Industry Mergers & Acquisitions
Energy Sector Developments
Workplace Trends
Funding Rounds & Investments
CEO Changes
AI Applications
Private Equity Deals
Emerging Startups
Fintech Startups
AI Innovations
Global Financial Events
Central Bank Actions
Countries:
Companies:
Apple Inc.
Google Inc.
Tesla, Inc.
Amazon.com, Inc.
Microsoft Corporation
Tesmec S.p.A.
Alphabet Inc.
OpenAI ERC USD
Walmart Inc.
SWIGGY LIMITED
TENCENT
NVIDIA Corporation
Foxconn Technology Co., Ltd.
Hollywood Bowl Group PLC
NASDAQ Composite
Wise plc
Mastercard Inc
Bose Corporation
Mistral 1
Fast Retailing Co., Ltd.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
British Pound Sterling
United Arab Emirates Dirham
Vietnamese Đồng
South Korean Won
New Zealand Dollar
Saudi Riyal
Thai Baht
Australian Dollar
Indonesian Rupiah
Singapore Dollar
Omani Rial
Bahraini Dinar
Qatari Riyal
Algerian Dinar
Egyptian Pound
People: